JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubanyi, G. M.
Right arrow Articles by Sybertz, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubanyi, G. M.
Right arrow Articles by Sybertz, E. J.

Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels

GM Rubanyi, D Desiderio, A Luisi, A Johns and EJ Sybertz

Department of Pharmacology, Berlex Laboratories, Cedar Knolls, New Jersey.

The effects of phorbol esters on endothelium-dependent relaxations evoked by ACh and the calcium ionophore A23187 were analyzed in isolated canine femoral and coronary arteries mounted in organ chambers or in a bioassay system. In rings of femoral and coronary arteries, phorbol 12,13-dibutyrate (PDBu) (10(-7) M) evoked contraction (ED50 2.9 x 10(-8) M) and depressed endothelium-dependent relaxations to ACh (4- fold increase in ED50 and 72% depression of maximal response). PDBu depressed maximal relaxations to A23187 by 50% but had no effect on ED50. The inactive phorbol ester 4-alpha-phorbol didecanoate (10(-7) M) did not evoke contractions and had no effect on endothelium-dependent relaxations to ACh or A23187. Endothelium-independent relaxations to sodium nitroprusside were not effected by PDBu (10(-7) M) in femoral or coronary arteries. In bioassay experiments, selective treatment of perfused femoral artery segments with PDBu (10(-8)-10(-6) M) caused concentration-dependent inhibition of basal and ACh- (10(-6) M) and A23187-(10(-6) M) induced release of endothelium-derived relaxing factor (EDRF) (as assessed by relaxation of superfused bioassay coronary artery rings without endothelium). PDBu inhibited these responses with different potency: basal (10(-8) M) greater than ACh (10(-7) M) much greater than A23187 (only partial inhibition at 10(-6) M).(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 249, Issue 3, pp. 858-863, 06/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Sud, S. Wedgwood, and S. M. Black
Protein kinase C{delta} regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L582 - L591.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Long, L. G. Cook, S. L. Hamilton, G.-Y. Wu, and B. M. Mitchell
FK506 Binding Protein 12/12.6 Depletion Increases Endothelial Nitric Oxide Synthase Threonine 495 Phosphorylation and Blood Pressure
Hypertension, March 1, 2007; 49(3): 569 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Omiyi, R. J. Brue, P. Taormina II, M. Harvey, N. Atkinson, and L. H. Young
Protein Kinase C {beta}II Peptide Inhibitor Exerts Cardioprotective Effects in Rat Cardiac Ischemia/Reperfusion Injury
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 542 - 551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Phillipson, E. E. Peterman, P. Taormina Jr., M. Harvey, R. J. Brue, N. Atkinson, D. Omiyi, U. Chukwu, and L. H. Young
Protein kinase C-{zeta} inhibition exerts cardioprotective effects in ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H898 - H907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. H. Young, Y. Ikeda, and A. M. Lefer
Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2489 - H2495.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Li, S. A. Oehrlein, T. Wallerath, I. Ihrig-Biedert, P. Wohlfart, T. Ulshöfer, T. Jessen, T. Herget, U. Förstermann, and H. Kleinert
Activation of Protein Kinase Calpha and/or epsilon  Enhances Transcription of the Human Endothelial Nitric Oxide Synthase Gene
Mol. Pharmacol., April 1, 1998; 53(4): 630 - 637.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Cowan and R. P. Steffen
Lysophosphatidylcholine Inhibits Relaxation of Rabbit Abdominal Aorta Mediated by Endothelium-Derived Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor Independent of Protein Kinase C Activation
Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2290 - 2297.
[Abstract] [Full Text]


Home page
HypertensionHome page
Y. Ohara, H. S. Sayegh, J. J. Yamin, and D. G. Harrison
Regulation of Endothelial Constitutive Nitric Oxide Synthase by Protein Kinase C
Hypertension, March 1, 1995; 25(3): 415 - 420.
[Abstract] [Full Text]


Home page
HypertensionHome page
K.-i. Hirata, R. Kuroda, T. Sakoda, M. Katayama, N. Inoue, M. Suematsu, S. Kawashima, and M. Yokoyama
Inhibition of Endothelial Nitric Oxide Synthase Activity by Protein Kinase C
Hypertension, February 1, 1995; 25(2): 180 - 185.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.